<DOC>
	<DOCNO>NCT00716274</DOCNO>
	<brief_summary>This study evaluate effect atomoxetine brain activation attention read task via functional Magnetic Resonance Imaging ( fMRI ) patient age 10 16 year old ADHD comorbid dyslexia</brief_summary>
	<brief_title>Effects Atomoxetine Brain Activation During Attention Reading Tasks Patients With ADHD &amp; Comorbid Dyslexia</brief_title>
	<detailed_description>This randomize , placebo-controlled , double-blind , single site study use fMRI measurement ass brain activation attention read task effect atomoxetine reduce symptom ADHD patient ADHD comorbid dyslexia . Similar assessment perform two additional group patient ADHD dyslexia determine extent symptomatic change comorbid ADHD &amp; dyslexia achieve independently atomoxetine effect either condition . A healthy control group non-ADHD , non-dyslexia subject ( 20 ) include monitor practice effect &amp; effect treatment may interpret normal maturation . The healthy control group treat study medication .</detailed_description>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Dyslexia</mesh_term>
	<mesh_term>Atomoxetine Hydrochloride</mesh_term>
	<criteria>Patients must meet DSMIVTR criterion ADHD Patient must meet DSMIVTR criterion dyslexia Patients must achieve score 80 Full Scale Intelligence Quotient Child adolescent patient must 10 16 year old Must able communicate English Must able swallow capsule Be reliable keep appointment clinic visit &amp; related test Subjects healthy control group meet DSMIVTR criterion AHHD and/or dyslexia Subjects healthy control group must achieve score least 80 &gt; 120 Full Scale Intelligence Quotient Patients weigh less 25 kg great 70 kg Patients severe allergy 1 class medication multiple adverse drug reaction Patients prior diagnosis bipolar I bipolar II disorder psychosis Patients document history autism , Asperger 's syndrome , pervasive developmental disorder Females pregnant breastfeeding Patients treat atomoxetine therapeutic dose ( 1.2 mg/kg/day ) least 4 6 week</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>